Streetbeat News

Analyst Ratings

BPMC

Barclays analyst Peter Lawson maintains an Equal-Weight rating on Blueprint Medicines (NASDAQ:BPMC) and raises the price target from $44 to $46.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 9:36 am

ZIM

Barclays analyst Alexia Dogani maintains an Underweight rating on ZIM Integrated Shipping (NYSE:ZIM) and lowers the price target from $15 to $13.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 9:35 am

RAIN

Piper Sandler analyst Joseph Catanzaro downgraded Rain Oncology (NASDAQ: RAIN) from Overweight to Neutral and lowered the price target from $15 to $1.75.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 9:35 am

CRSP

Citigroup analyst Yigal Nochomovitz maintains a Neutral rating on CRISPR Therapeutics (NASDAQ:CRSP) and raises the price target from $55 to $70.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 9:34 am

HUBS

Jefferies analyst Samad Samana maintains a Buy rating on HubSpot (NYSE:HUBS) and raises the price target from $500 to $570.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 9:23 am

SNDR

Stifel analyst Bert Subin maintains a Buy rating on Schneider National (NYSE:SNDR) but lowers the price target from $35 to $33.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 9:20 am

NUE

JP Morgan analyst Michael Glick initiates coverage on Nucor (NYSE:NUE) with an Underweight rating and announces a price target of $130.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 9:20 am

QTRX

Goldman Sachs analyst Matthew Sykes upgrades Quanterix (NASDAQ:QTRX) from Neutral to Buy and raises the price target from $13 to $27.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 9:15 am

MYGN

Goldman Sachs analyst Matthew Sykes upgrades Myriad Genetics (NASDAQ:MYGN) from Sell to Buy and raises the price target from $18 to $25.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 9:14 am

RH

Telsey Advisory Group analyst Joseph Feldman has reiterated a Market Perform rating on RH (NYSE:RH) and maintained a $225 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 9:08 am